Skip to main content

Factors Controlling Pharmacokinetics of Intravenously Injected Nanoparticulate Systems

  • Chapter
Nanotechnology in Drug Delivery

Part of the book series: Biotechnology: Pharmaceutical Aspects ((PHARMASP,volume X))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 179.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 229.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Al-Hanbali, O., Rutt, K. J., Sarker, D. K., Hunter, A. C., & Moghimi, S. M. (2006). Concentration dependent structural ordering of poloxamine 908 on polystyrene nanoparticles and their modulatory role on complement consumption. J. Nanosci. Nanotechnol., 6, 3126–3133.

    Article  CAS  PubMed  Google Scholar 

  • Andresen, T. L., Jensen, S. S., & Jørgensen, K. (2004). Advanced strategies in liposomal cancer therapy: problems and prospects of active tumor specific drug release. Prog. Lipid Res., 44, 68–97.

    Article  Google Scholar 

  • Allen, T. M. (2002). Ligand-targeted therapeutics in anticancer therapy. Nat. Rev. Cancer, 2, 750–763.

    Article  CAS  PubMed  Google Scholar 

  • Bendas, G., Rothe, U., Scherphof, G. L., & Kamps, J. A. A. M. (2003). The influence of repeated injections on pharmacokinetics and biodistribution of different types of sterically stabilized immunoliposomes. Biochim. Biophys. Acta, 1609, 63–70.

    Article  CAS  PubMed  Google Scholar 

  • Bhatia, S. K., King, M. R., & Hammer, D. A. (2003). The state diagram for cell adhesion mediated by two receptors. Biophys. J., 84, 2671–2690.

    Article  CAS  PubMed  Google Scholar 

  • Charrois, G. J. R., & Allen, T. M. (2003). Multiple injections of PEGylated liposomal doxorubicin: pharmacokinetics and therapeutic activity. J. Pharmacol. Exp. Ther., 306, 1058–1067.

    Article  CAS  PubMed  Google Scholar 

  • Cherukuri, P., Gannon, C. J., Leeuw, T. K., Schmidt, H. K., Smalley, R. E., Curley, S. A., & Weisman, R. B. (2006). Mammalian pharmacokinetics of carbon nanotubes using intrinsic near-infrared fluorescence. Proc. Natl. Acad. Sci. USA, 103, 18882–18886.

    Article  CAS  PubMed  Google Scholar 

  • Chonn, A., Semple, S. C., & Cullis, P. R. (1992). Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes. J. Biol. Chem., 267, 18759–18765.

    CAS  PubMed  Google Scholar 

  • Chonn, A., Semple, S. C., & Cullis, P. R. (1995). β2-Glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of ‘non-self’ particles. J. Biol. Chem., 270, 25845–25849.

    Article  CAS  PubMed  Google Scholar 

  • Cornacoff, J. B., Hebert, L. A., Smead, W. L., & Van Aman, M. E. (1983). Primate erythrocyte-immune complex-clearing mechanism. J. Clin. Invest., 71, 236–247.

    Article  CAS  PubMed  Google Scholar 

  • Dams, E. T. M., Laverman, P., Oyen, W. J. G., Storm, G., Scherphof, G. L., Van der Meer, J. W. M., Corstens, F. H., & Boerman, O. C. (2000). Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. J. Pharmacol. Exp. Ther., 292, 1071–1079.

    CAS  PubMed  Google Scholar 

  • Decuzzi, P., & Ferrari, M. (2006). The adhesive strength of non-spherical particles mediated by specific interactions. Biomaterials, 27, 5307–5314.

    Article  CAS  PubMed  Google Scholar 

  • Devine, D. V., Wong, K., Serrano, K., Chonn, A., & Cullis, P. R. (1994). Liposome-complement interactions in rat serum: implications for liposome survival studies. Biochim. Biophys. Acta, 1191, 43–51.

    Article  CAS  PubMed  Google Scholar 

  • Gbadamosi, J. K., Hunter, A. C., & Moghimi, S. M. (2002). PEGylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performance. FEBS Lett., 532, 338–344.

    Article  CAS  PubMed  Google Scholar 

  • Harisinghani, M. G., Barentsz, J., Hahn, P. F., Deserno, W. M., Tabatabaei, S., Hulsbergen van de Kaa, C., de la Rosette, J., & Weissleder, R. (2003). Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. New Engl. J. Med., 348, 2491–2499.

    Google Scholar 

  • Harush-Frenkel, O., Debotton, N., Benita, S., & Altschuler, Y. (2007). Targeting of nanoparticles to the clathrin-mediated endocytic pathway. Biochem. Biophys. Res. Commun., 353, 26–32.

    Article  CAS  PubMed  Google Scholar 

  • Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998). Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc. Natl. Acad. Sci. USA, 95, 4607–4612.

    Article  CAS  PubMed  Google Scholar 

  • Ishida, T., Atobe, K., Wang, X., & Kiwada, H. (2006a). Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection. J. Control. Rel., 115, 251–258.

    Article  CAS  Google Scholar 

  • Ishida, T., Ichihara, M., Wang, X., & Kiwada, H. (2006b). Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes. J. Control. Rel., 115, 243–250.

    Article  CAS  Google Scholar 

  • Ishida, T., Maeda, R., Ichihara, M., Irimura, K., & Kiwada, H. (2003). Accelerated clearance of PEGylated liposomes in rats after repeated injections. J. Control. Rel., 88, 35–42.

    Article  CAS  Google Scholar 

  • Klumpp, C., Kostarelos, K., Prato, M., & Bianco, A. (2006). Functionalized carbon nanotubes as emerging nanovectors for the delivery of therapeutics. Biochim. Biophys. Acta, 1758, 404–412.

    Article  CAS  PubMed  Google Scholar 

  • Kreuter, J., Ramge, P., Petrov, V., Hamm, S., Gelperina, S. E., Engelhardt, B., Alyautdin, R., von Briesen, H., & Begley, D. J. (2003). Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drugs to the nanoparticles. Pharm. Res., 20, 409–416.

    Article  CAS  PubMed  Google Scholar 

  • Liu, Z., Cai, W., He, L., Nakayama, N., Chen, K., Sun, X., Chen, X., & Dai, H. (2006). In vivo distribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat. Nanotechnol., 2, 47–52.

    Article  PubMed  Google Scholar 

  • Loughrey, H. C., Bally, M. B., Reinish, L. W., & Cullis, P. R. (1990). The binding of phosphatidylglycerol liposomes to rat platelets is mediated by complement. Thromb. Haemost., 64, 172–176.

    CAS  PubMed  Google Scholar 

  • Lovrić, J., Cho, S. J., Winnik, F. M., & Maysinger, D. (2005). Unmodified cadmium telluride quantum dots induce reactive oxygen species formation leading to multiple organelle damage and cell death. Chem. Biol., 12, 1227–1234.

    Article  PubMed  Google Scholar 

  • Lyass, O., Uziely, B., Ben-Yosef, R., Tzemach, D., Heshing, N. I., Lotem, M., Brufman, G., & Gabizon, A. (2000). Correlation of toxicity with pharmacokinetics of PEGylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma. Cancer, 89, 1037–1047.

    Article  CAS  PubMed  Google Scholar 

  • Marjan, J., Xie, Z., & Devine, D. V. (1994). Liposome-induced activation of the classical complement pathway does not require immunoglobulin. Biochim. Biophys. Acta, 1192, 35–44.

    Article  CAS  PubMed  Google Scholar 

  • Moghimi, S. M. (1995). Exploiting bone marrow microvascular structure for drug delivery and future therapies. Adv. Drug Deliv. Rev., 17, 61–73.

    Article  CAS  Google Scholar 

  • Moghimi, S. M. (2003). Exploitation of macrophage clearance functions. In S. Gordon (Ed.), Hand-Book of Experimental Pharmacology: The macrophage as therapeutic target, Volume 158 (pp. 41–54). Berlin: Springer-Verlag.

    Google Scholar 

  • Moghimi, S. M. (2006). Recent development in polymeric nanoparticle engineering and their applications in experimental and clinical oncology. Anti-cancer Agent. Med. Chem., 6, 553–561.

    Article  CAS  Google Scholar 

  • Moghimi, S. M. (2007a). Passive targeting of solid tumors: pathophysiological principles and physicochemical aspects of delivery systems. In M. M. Amiji (Ed.), Nanotechnology for cancer therapy (p. 11–18). Boca Raton: CRC Press.

    Google Scholar 

  • Moghimi, S. M. (2007b). Nanotoxicology of synthetic gene-transfer vectors: poly(ethylenimine)- and polyfectin-mediated membrane damage and apoptosis in human cell lines. In C. S. S. R. Kumar (Ed.), Nanotechnologies for Life Sciences: Nanomaterials for medical diagnosis and therapy, Volume 10 (pp. 629–643). Berlin: Wiley-VCH Verlag.

    Google Scholar 

  • Moghimi, S. M., & Bonnemain, B. (1999). Subcutaneous and intravenous delivery of diagnostic agents to the lymphatic system: applications in lymphoscintigraphy and indirect lymphography. Adv. Drug Deliv. Rev., 37, 295–312.

    Article  CAS  PubMed  Google Scholar 

  • Moghimi, S. M., & Gray, T. (1997). A single dose of intravenously injected poloxamine-coated long-circulating particles triggers macrophage clearance of subsequent doses in rats. Clin. Sci. (Lond.) 93, 371–379.

    CAS  Google Scholar 

  • Moghimi, S. M., Hamad, I., Andresen, T. L., Jørgensen, K., & Szebeni, J. (2006a). Methylation of the phosphate oxygen moiety of phospholipids-methoxy(polyethylene glycol) conjugate prevents PEGylated liposome-mediated complement activation and anaphylatoxin production. FASEB J., 20, 2591–2593 (doi: 10.1096/fj.06-6186fje, electronic pages: E2057–E2067).

    Article  CAS  Google Scholar 

  • Moghimi, S. M., Hamad, I., Bünger, R., Andresen, T. L., Jørgensen, K., Hunter, A. C., Baranji, L., Rosivall, L., & Szebeni, J. (2006b). Activation of the human complement system by cholesterol-rich and PEGylated liposomes–Modulation of cholesterol-rich liposome-mediated complement activation by elevated serum LDL and HDL levels. J. Liposome Res., 16, 167–174.

    Article  CAS  Google Scholar 

  • Moghimi, S. M., Hedeman, H., Muir, I. S., Illum, L., & Davis, S. S. (1993a). An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rats. Biochim. Biophys. Acta, 1157, 233–240.

    CAS  Google Scholar 

  • Moghimi, S. M., & Hunter, A. C. (2001). Recognition by macrophages and liver cells of opsonized phospholipids vesicles and phospholipids headgroups. Pharm. Res., 18, 1–8.

    Article  CAS  Google Scholar 

  • Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001). Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev., 53, 283–318.

    CAS  PubMed  Google Scholar 

  • Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005a). Nanomedicine: current status and future prospects. FASEB J., 19, 311–330.

    Article  CAS  Google Scholar 

  • Moghimi, S. M., Hunter, A. C., Murray, J. C., & Szewczyk, A. (2004). Cellular distribution of non-ionic micelles. Science, 303, 626–627.

    Article  CAS  PubMed  Google Scholar 

  • Moghimi, S. M., & Kissel, T. (2006). Particulate nanomedicines. Adv. Drug Deliv. Rev., 58, 1451–1455.

    Article  CAS  PubMed  Google Scholar 

  • Moghimi, S. M., Muir, I. S., Illum, L., Davis, S. S., & Kolb-Bachofen, V. (1993b). Coating particles with a block copolymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. Biochim. Biophys. Acta, 1179, 157–165.

    Article  CAS  Google Scholar 

  • Moghimi, S. M., Porter, C. J. H., Muir, I. S., Illum, L., & Davis, S. S. (1991). Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. Biochem. Biophys. Res. Commun., 177, 861–866.

    Article  CAS  PubMed  Google Scholar 

  • Moghimi, S. M., Symonds, P., Murray, J. C., Hunter, A. C., Debska, G., & Szewczyk, A. (2005b). A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene-transfer/therapy. Mol. Ther., 11, 990–995.

    Article  CAS  Google Scholar 

  • Moghimi, S. M., & Szebeni, J. (2003). Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog. Lipid Res., 42, 463–478.

    Article  CAS  PubMed  Google Scholar 

  • Moghimi, S. M., Vegas, E., Garcia, M. L., Al-Hanbali, O. A. R., & Rutt, K. J. (2006c). Polymeric nanoparticles as drug carriers and controlled release implant devices. In V. P. Torchilin (Ed.), Nanoparticles as drug carriers (p. 29–42). London: Imperial College Press.

    Chapter  Google Scholar 

  • Moore, Jr. F. D., Austen, K. F., & Fearon, D. T. (1982). Antibody restores human alternative complement pathway activation by mouse erythrocytes rendered functionally deficient by pre-treatment with pronase. J. Immunol., 128, 1302–1306.

    CAS  PubMed  Google Scholar 

  • Munn, L. L. (2003). Aberrant vascular architecture in tumors and its importance in drug-based therapies. Drug Discov. Today, 8, 396–403.

    Article  PubMed  Google Scholar 

  • Murray, J. C., & Moghimi, S. M. (2003). Endothelial cells as therapeutic targets in cancer: new biology and novel delivery systems. Crit. Rev. Ther. Drug Carr. Syst., 20, 139–152.

    Article  CAS  Google Scholar 

  • Patil, V. R. S., Campbell, C. J., Yun, Y. H., Slack, S. M., & Goettz, D. J. (2001). Particle diameter influences adhesion under flow. Biophys. J., 80, 1733–1743.

    Article  Google Scholar 

  • Porter, C. J. H., Moghimi, S. M., Illum, L., & Davis, S. S. (1992). The polyoxyethylene/polyoxypropylene block co-polymer poloxamer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow. FEBS Lett., 305, 62–66.

    Article  CAS  PubMed  Google Scholar 

  • Poznansky, M., & Juliano, R. L. (1984). Biological approaches to controlled delivery of drugs: a critical review. Pharmacol. Rev., 36, 277–336.

    CAS  PubMed  Google Scholar 

  • Qiang, Y., Antony, J., Sharma, A., Nutting, J., Sikes, D., & Meyer, D. (2006). Iron/iron oxide core-shell nanoclusters for biomedical applications. J. Nanoparticle Res., 8, 489–496.

    Article  CAS  Google Scholar 

  • Roberts, J. C., Bhalgat, M. K., & Zera, R. T. (1996). Preliminary biological evaluation of polyamidoamine (PAMAM) Starburst dendrimers. J. Biomed. Mat. Res., 30, 53–65.

    Article  CAS  Google Scholar 

  • Romberg, B., Oussoren, C., Snel, C. J., Carstens, M. G., Hennink, W. E., & Storm, G. (2007). Pharmacokinetics of poly(hydroxyethyl-L-asparagine)-coated liposomes is superior over that of PEG-coated liposomes at low lipid dose and upon repeated administration. Biochim. Biophys. Acta , doi: 10.1016/j.bbamem.2006.12.005, 1768, 2655–2666.

    Google Scholar 

  • Romero, E. L., Morilla, M. J., Regts, J., Koning, G. A., & Scherphof, G. L. (1999). On the mechanism of hepatic transendothelial passage of large liposomes. FEBS Lett., 448, 193–196.

    Article  CAS  PubMed  Google Scholar 

  • Salvador-Morales, C., Flahaut, E., Sim, E., Sloan, J., Green, M. L. H., & Sim, R. B. (2006). Complement activation and protein adsorption by carbon nanotubes. Mol. Immunol., 43, 193–201.

    Article  CAS  PubMed  Google Scholar 

  • Scherphof, G. L., & Kamps, J. A. A. M. (2001). The role of hepatocytes in the clearance of liposomes from the blood circulation. Prog. Lipid Res., 40, 149–166.

    Article  CAS  PubMed  Google Scholar 

  • Singh, R., Pantarotto, D., lacerda, L., Pastorin, G., Klumpp, C., Prato, M., Bianco, A., & Kostarelos, K. (2006). Tissue distribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc. Natl. Acad. Sci. USA, 103, 3357–3362.

    Article  CAS  PubMed  Google Scholar 

  • Sou, K., Goins, B., Takeoka, S., Tsuchida, E., & Phillips, W. T. (2006). Selective uptake of surface-modified vesicles by bone marrow macrophages in vivo. Biomaterials, 28, 2655–2666.

    Google Scholar 

  • Sudimack, J., & Lee, R. J. (2000). Targeted drug delivery via the folate receptor. Adv. Drug Deliv. Rev., 41, 147–162.

    Article  CAS  PubMed  Google Scholar 

  • Volanakis, J. E., & Wirtz, K. W. A. (1979). Interaction of C-reactive protein with artificial phosphatidylcholine bilayers. Nature, 281, 155–157.

    Article  CAS  PubMed  Google Scholar 

  • Yan, X., Kuipers, F., Havekes, L. M., Havinga, R., Dontje, B., Poelstra, K., Scherphof, G. L., & Kamps, J. A. A. M. (2005). The role of lipoprotein E in the elimination of liposomes from blood by hepatocytes in the mouse. Biochem. Biophys. Res. Commun., 328, 57–62.

    Article  CAS  PubMed  Google Scholar 

  • Yan, X., Morselt, H. W. M., Scherphof, G. L., Poelstra, K., & Kamps, J. A. A. M. (2004). The role of beta(2)-glycoprotein I in liposome-hepatocyte interaction. Biochim. Biophys. Acta, 1667, 208–214.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 American Association of Pharmaceutical Scientists

About this chapter

Cite this chapter

Moghimi, S.M., Hamad, I. (2009). Factors Controlling Pharmacokinetics of Intravenously Injected Nanoparticulate Systems. In: de Villiers, M.M., Aramwit, P., Kwon, G.S. (eds) Nanotechnology in Drug Delivery. Biotechnology: Pharmaceutical Aspects, vol X. Springer, New York, NY. https://doi.org/10.1007/978-0-387-77668-2_9

Download citation

Publish with us

Policies and ethics